The Latest Cardiac and Vascular News
ZOLL AED 3 and ZOLL AED 3 BLS Recognized by World of Safety & Health Asia for Their Innovative Technology for All Rescuers CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that its ZOLL AED 3® and ZOLL AED 3 BLS automated […]
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter Ventricular Restoration (TCVR), today announced that heart failure specialist Jerry Estep, MD, of the Cleveland Clinic has been appointed co-principal investigator of the pivotal ALIVE Trial studying LIVE™ Therapy using the Revivent TC™ […]
Atrial functional mitral regurgitation (aFMR) is associated with left atrial (LA) and mitral annular dilatation most often caused by atrial fibrillation or heart failure with preserved ejection fraction (HFpEF). (A) Echocardiographic assessment, (B) functional mitral regurgitation classification, (C) New York Heart Association classification, and (D) mitral annulus diameter at baseline, […]
MARSEILLE, France, Jan. 5, 2021 /PRNewswire/ — Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised 28 million USD. The financing round was led by Gilde Healthcare with participation of existing shareholder Pasteur Mutualité. The new capital will […]
Breakthrough Therapy Now Commercially Available in South America’s Most Populous Country MARLTON, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the first patient in Brazil was treated with its innovative CCM® therapy delivered by the Optimizer® system. The patient was treated […]
ANDOVER, Mass. and VALHALLA, N.Y., Jan. 5, 2021 /PRNewswire/ — Retia Medical is the first company to utilize Capsule Technologies’ new Device Driver Interface (DDI) development strategy to integrate its Argos Cardiac Monitor, the companies announced today. Capsule’s new DDI development strategy uses the Integrating Healthcare Enterprise-Patient Care Device (IHE-PCD) framework to speed device connectivity […]
Neuronaute® EEG System and IceCap® bring Comprehensive Remote Electroencephalography Monitoring Services to People Living with Neurological Disorders. PARIS and ATLANTA, Jan. 5, 2021 /PRNewswire/ — BioSerenity, Inc., a leading global provider of remote diagnostic solutions in the areas of Neurology, Cardiology and Sleep Disorders announced today it received U.S. Food and Drug Administration (FDA) 510(k) […]
In the SafePass 2 clinical study, the Emboliner™ demonstrated excellent safety and technical performance, and captured five times more debris than commercially-available devices SANTA CRUZ, Calif., Jan. 5, 2021 /PRNewswire/ — Emboline, Inc., a privately held medical technology company focused on reducing stroke during transcatheter heart procedures, today announced it completed raising over $10 […]
Paul Verrastro Named CMO and Thomas Hengsteler Named VP of European Sales and Marketing MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) — CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that it is expanding its senior leadership team by adding two medical […]
Biotres is a compact and discreet 3 channel holter solution REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA), on December 31 2020, for Biotres. The company expects this process to take […]
